Hostname: page-component-89b8bd64d-ktprf Total loading time: 0 Render date: 2026-05-05T12:03:56.602Z Has data issue: false hasContentIssue false

Estimating age-time-dependent malaria force of infection accounting for unobserved heterogeneity

Published online by Cambridge University Press:  05 July 2017

L. MUGENYI*
Affiliation:
Infectious Diseases Research Collaboration, Plot 2C Nakasero Hill Road, Kampala, Uganda Center for Statistics, Interuniversity Institute for Biostatistics and statistical Bioinformatics, UHasselt (Hasselt University), Diepenbeek, Belgium
S. ABRAMS
Affiliation:
Center for Statistics, Interuniversity Institute for Biostatistics and statistical Bioinformatics, UHasselt (Hasselt University), Diepenbeek, Belgium
N. HENS
Affiliation:
Center for Statistics, Interuniversity Institute for Biostatistics and statistical Bioinformatics, UHasselt (Hasselt University), Diepenbeek, Belgium Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
*
*Author for correspondence: L. Mugenyi, Hasselt University, Agoralaan 1, 3590 Diepenbeek, Belgium. (Email: levicatus.mugenyi@uhasselt.be)
Rights & Permissions [Opens in a new window]

Summary

Despite well-recognized heterogeneity in malaria transmission, key parameters such as the force of infection (FOI) are generally estimated ignoring the intrinsic variability in individual infection risks. Given the potential impact of heterogeneity on the estimation of the FOI, we estimate this quantity accounting for both observed and unobserved heterogeneity. We used cohort data of children aged 0·5–10 years evaluated for the presence of malaria parasites at three sites in Uganda. Assuming a Susceptible–Infected–Susceptible model, we show how the FOI relates to the point prevalence, enabling the estimation of the FOI by modelling the prevalence using a generalized linear mixed model. We derive bounds for varying parasite clearance distributions. The resulting FOI varies significantly with age and is estimated to be highest among children aged 5–10 years in areas of high and medium malaria transmission and highest in children aged below 1 year in a low transmission setting. Heterogeneity is greater between than within households and it increases with decreasing risk of malaria infection. This suggests that next to the individual's age, heterogeneity in malaria FOI may be attributed to household conditions. When estimating the FOI, accounting for both observed and unobserved heterogeneity in malaria acquisition is important for refining malaria spread models.

Information

Type
Original Papers
Copyright
Copyright © Cambridge University Press 2017 
Figure 0

Fig. 1. A schematic diagram of the SIS compartmental model illustrating the simplified dynamics for malaria transmission.

Figure 1

Table 1. General structures for the FOI according to different link functions in a GLMM framework

Figure 2

Table 2. Recruited number of children, baseline and monthly parasite prevalence, by study site and age group

Figure 3

Fig. 2. Proportion of children infected with malaria parasites (parasitaemia) in a cohort followed for 3 years, by study site (Nagongera, Kihihi and Walukuba) in Uganda based on data from August 2011 to August 2014 with the size of the dots proportional to the number of observations. (A) Observed parasitaemia varying with age; (B) observed parasitaemia varying with calendar time.

Figure 4

Table 3. Estimates of the fitted GLMM using a fractional polynomial of degree 1 for age and a logit-link function

Figure 5

Fig. 3. The lower bound (green) for the marginal annual FOI and the difference between upper and lower bound (yellow) with full bar showing the upper bound for the FOI, by study site, age group (A, <1 year; B, 1–4 years; and C, 5–10 years) and the infection status at the previous visit and past use of AL (negative and no AL in the past (left column), negative and AL in the past (second left column), symptomatic (second right column) and asymptomatic (right column)) for children assumed to be born in the baseline year (2001). Top row, Nagongera; middle row, Kihihi; bottom row, Walukuba.

Figure 6

Fig. 4. Top row: Individual-specific evolutions for the conditional annual FOI obtained using the lower boundary estimator, by study site for children assumed to be symptomatic at the previous visit and who were born in the baseline year (2001). Bottom row: The marginal annual FOI, obtained using the lower boundary estimator, by study site and the infection status at the previous visit and past use of AL (negative and no AL in the past (solid lines), negative and AL in the past (dotted lines), symptomatic (dash-dotted lines) and asymptomatic (long-dashed lines)). Left column, Nagongera; middle column, Kihihi; right column, Walukuba.

Figure 7

Fig. 5. Top row: The marginal annual FOI (contour lines) considering different values for the clearance rate ranging from 0 to 3 years−1 by study site for individuals assumed to be symptomatic at the previous visit and were born in the baseline year. Bottom row: The marginal annual FOI, obtained using the upper boundary estimator, for individuals assumed to be symptomatic at the previous visit, by study site, birth year (2001, 2004, 2007 and 2010) and by age group (A: <1 year, B: 1–4 years, and C: 5–10 years). Left panel, Nagongera; middle panel, Kihihi; right panel, Walukuba.

Figure 8

Fig. A1. Plots for log-likelihood versus the clearance rate (left panel) and FOI versus the clearance rate (right panel) obtained after fitting 1000 models to the data according to π = λ/(λ + γ)(1 − e−(λ+γ)a) as given by Pull and Grab (1974) by choosing values for the annual clearance rate on a grid of 0·1 to 2·0 with a step size of 0·0019.

Figure 9

Fig. A2. Top row: Individual-specific evolutions for the conditional prevalence, by study site for children assumed to be symptomatic at the previous visit and were born in the baseline year (2001). Bottom row: Average evolutions for marginalized prevalence, by study site and the infection status at the previous visit and past use of AL (negative and no AL in the past (solid lines), negative and AL in the past (dotted lines), symptomatic (dash-dotted lines) and asymptomatic (long-dashed lines)). Left panel: Nagongera, middle panel: Kihihi, right panel: Walukuba.

Figure 10

Table A1. Overview of the fractional polynomial model selection

Figure 11

Table A2. Overview of model building (number of observations in each case equal to 8645)

Figure 12

Table A3; Maximum values for the marginal annual FOI by study site, previous infection status and use of AL, and by age group

Figure 13

Table A4; Marginal FOI and the 95% confidence bounds for the age- and time-dependent marginal annual FOI by study site, previous infection status and use of AL, and by age group for children born in the baseline year (2001)